According to Onconova Therapeutics's latest financial reports the company's current revenue (TTM ) is โฌ0.22 Million. In 2023 the company made a revenue of โฌ0.2 Million a decrease over the revenue in the year 2022 that were of โฌ0.21 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | โฌ0.2 M | 2.13% |
2023 | โฌ0.2 M | -2.97% |
2022 | โฌ0.21 M | 5.58% |
2021 | โฌ0.19 M | 6.26% |
2020 | โฌ0.18 M | -90.36% |
2019 | โฌ1.94 M | 81.54% |
2018 | โฌ1.07 M | 63.65% |
2017 | โฌ0.65 M | -87.56% |
2016 | โฌ5.27 M | -49.68% |
2015 | โฌ10.47 M | 1492.84% |
2014 | โฌ0.65 M | -80.89% |
2013 | โฌ3.44 M | -90.14% |
2012 | โฌ34.91 M |